Okamoto H - Search Results

1

Prevalence of psychological distress and associated factors among patients undergoing comprehensive genomic profiling testing: protocol for a multicentre, prospective, observational study.

Matsuoka A, Fujimori M, Koyama T, Sato A, Mori K, Hirata M, Tanabe N, Nakachi K, Kato S, Okamoto H, Ogawa K, Komatsu H, Iwasaku M, Miyaji T, Uchitomi Y. Matsuoka A, et al. Among authors: okamoto h. BMJ Open. 2023 Nov 23;13(11):e072472. doi: 10.1136/bmjopen-2023-072472. BMJ Open. 2023. PMID: 37996226 Free PMC article.

2

Phase II study of nab-paclitaxel + carboplatin for patients with non-small-cell lung cancer and interstitial lung disease.

Kenmotsu H, Yoh K, Mori K, Ono A, Baba T, Fujiwara Y, Yamaguchi O, Ko R, Okamoto H, Yamamoto N, Ninomiya T, Ogura T, Kato T. Kenmotsu H, et al. Among authors: okamoto h. Cancer Sci. 2019 Dec;110(12):3738-3745. doi: 10.1111/cas.14217. Epub 2019 Nov 6. Cancer Sci. 2019. PMID: 31608537 Free PMC article. Clinical Trial.

3

Randomized, Phase II study of pemetrexed plus bevacizumab versus pemetrexed alone after treatment with cisplatin, pemetrexed, and bevacizumab in advanced non-squamous, non-small cell lung cancer: TORG (thoracic oncology research group) 1321.

Kasai T, Mori K, Nakamura Y, Seki N, Ichikawa Y, Saito H, Kondo T, Nishikawa K, Otsu S, Bessho A, Tanaka H, Yamaguchi H, Kaburagi T, Imai H, Mori K, Ohtake J, Okamoto H. Kasai T, et al. Among authors: okamoto h. Cancer Med. 2023 Jul;12(14):14988-14999. doi: 10.1002/cam4.6135. Epub 2023 May 24. Cancer Med. 2023. PMID: 37226421 Free PMC article. Clinical Trial.

4

Acute pancreatitis or severe increase in pancreatic enzyme levels following remdesivir administration in COVID-19 patients: an observational study.

Miyazaki K, Yoshimura Y, Miyata N, Sasaki H, Shiba A, Aga M, Hamakawa Y, Taniguchi Y, Misumi Y, Agemi Y, Shimokawa T, Okamoto H, Tachikawa N. Miyazaki K, et al. Among authors: okamoto h. Sci Rep. 2022 Mar 29;12(1):5323. doi: 10.1038/s41598-022-09170-4. Sci Rep. 2022. PMID: 35351942 Free PMC article.

5

Prospective evaluation of the G8 screening tool for prognostication of survival in elderly patients with lung cancer: A single-institution study.

Agemi Y, Shimokawa T, Sasaki J, Miyazaki K, Misumi Y, Sato A, Aida S, Ishii M, Nakamura Y, Naoki K, Okamoto H. Agemi Y, et al. Among authors: okamoto h. PLoS One. 2019 Jan 17;14(1):e0210499. doi: 10.1371/journal.pone.0210499. eCollection 2019. PLoS One. 2019. PMID: 30653558 Free PMC article.

6

Efficacy of PD-1 Inhibitors in Older Non-small Cell Lung Cancer Patients.

Nakamura Y, Miyazaki K, Aiko N, Misumi Y, Agemi Y, Taniguchi Y, Ishi M, Shimokawa T, Okamoto H, Yamanaka T. Nakamura Y, et al. Among authors: okamoto h. Anticancer Res. 2020 Feb;40(2):923-928. doi: 10.21873/anticanres.14025. Anticancer Res. 2020. PMID: 32014936

7

Rationale and protocol design of a phase II study of first-line osimertinib treatment for patients with poor performance status and EGFR mutation-positive non-small cell lung cancer (OPEN/TORG2040).

Fukui T, Sasaki J, Igawa S, Kada A, Saito TI, Kogure Y, Okamoto H, Naoki K. Fukui T, et al. Among authors: okamoto h. BMC Cancer. 2022 Dec 15;22(1):1314. doi: 10.1186/s12885-022-10409-6. BMC Cancer. 2022. PMID: 36522630 Free PMC article.

8

Continuation of osimertinib in EGFR-mutant non-small-cell lung cancer patients bearing CNS metastasis (EPONA study).

Okuma Y, Nomura S, Ninomiya K, Gyotoku H, Murakami S, Kogure Y, Harada D, Okishio K, Okamoto H, Goto Y. Okuma Y, et al. Among authors: okamoto h. Future Oncol. 2023 Jul;19(22):1515-1521. doi: 10.2217/fon-2022-1128. Epub 2023 Aug 14. Future Oncol. 2023. PMID: 37577772

9

Patterns and Incidence of Pneumonitis and Initial Treatment Outcomes with Durvalumab Consolidation Therapy after Radical Chemoradiotherapy for Stage III Non-Small Cell Lung Cancer.

Sato M, Odagiri K, Tabuchi Y, Okamoto H, Shimokawa T, Nakamura Y, Hata M. Sato M, et al. Among authors: okamoto h. Cancers (Basel). 2024 Mar 15;16(6):1162. doi: 10.3390/cancers16061162. Cancers (Basel). 2024. PMID: 38539497 Free PMC article.

10

[Management of adverse reactions caused by cancer chemotherapy in elderly patients].

Okamoto H, Watanabe K. Okamoto H, et al. Nihon Rinsho. 2003 Jun;61(6):1025-9. Nihon Rinsho. 2003. PMID: 12806955 Review. Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,524 results

Search Page